India today (April 12) approved the Russian Covid-19 vaccine for emergency use.
Sputnik V, developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, was granted an emergency use authorisation by India’s subject expert committee on vaccines. It will now be taken up by India’s drugs regulator for a final approval, and will be the third vaccine in India’s armour against the coronavirus pandemic.
The Russian Direct Investment Fund (RDIF), the country’s sovereign wealth fund, had in September 2020 tied up with Indian pharmaceutical company Dr Reddy’s Laboratories for clinical trials and production. Since then, several Indian drugmakers like Hetero and Panacea Biotech have made pacts with Dr Reddy’s and RDIF to produce the Sputnik V vaccine locally. Together, these companies can produce up to 850 million doses of vaccine annually.
Updated:
The broader NSE Nifty advanced 99.80 points or 0.68 per cent to 14,737.60.
Share Article
AAA
On April 6, 2021, the 30-share BSE index pared its initial losses and rebounded 313.14 points or 0.64 per cent to 49,472.46.
| Photo Credit:
PTI
The broader NSE Nifty advanced 99.80 points or 0.68 per cent to 14,737.60. After starting on a weak note, equity benchmark Sensex rebounded over 300 points in early trade on Tuesday, tracking gains in index heavyweights HDFC twins, Infosys and ICICI Bank. The 30-share BSE index pared its initial losses and rebounded 313.14 points or 0.64 per cent to 49,472.46, and the broader NSE Nifty advanced 99.80 points or 0.68 per cent to 14,737.60. PowerGrid was the top gainer in the Sensex pack, rising over 2 per cent, followed by M&M, NTPC, IndusInd Bank, Bajaj Finance, Sun Pharma, Dr Reddy’s, ICICI Bank, HDFC duo and Infosys.
Bull spread Strategy on Dr Reddy s Labs Buy DR REDDY S MARCH 4,600 Call at Rs 182 & simultaneously sell 4,800 Call at Rs 106
Lot Size: 125
Cost of the strategy: Rs 76 (Rs 9,500 per strategy)
Maximum profit: Rs 15,500 If Dr Reddy s closes at or above 4,800 on March 25 expiry.
Breakeven point: Rs 4,676
Rationale: Long build-up was seen in the Dr Reddy Futures’ where we have seen 4 per cent (Prov) rise in the Open Interest with price rising by 1 per cent. The stock price has broken out on the daily chart where it closed above 200-day EMA with higher volumes. The stock price has formed double bottom around 4,380-odd levels